Toxicologic Pathology
Toxicologic Pathology is dedicated to the promotion of human, animal, and environmental health through the dissemination of knowledge, techniques, and guidelines to enhance the understanding and practice of toxicologic pathology.
Toxicologic Pathology, the official journal of the Society of Toxicologic Pathology, the British Society of Toxicological Pathology and the European Society of Toxicologic Pathology, will publish Original Research Articles, Symposium Articles, Review Articles, Meeting Reports, New Techniques, and Position Papers that are relevant to toxicologic pathology. Relevant topics include reports on safety assessment of pharmaceuticals, chemicals, food additives, pesticides, environmentally relevant chemicals, and medical devices; risk characterization of xenobiotics; investigative studies that contribute to refinement of the safety assessment process; mechanistic studies that provide a basis for interpreting and predicting toxicologic outcome; emerging approaches and methods in toxicologic pathology; spontaneous diseases that may influence toxicology studies, and animal and alternative models relevant to toxicologic pathology. Studies of botanicals and their extracts must include appropriate characterization of the components and concentration of active ingredients; crude extracts will not be accepted. Reviews may be contributed or invited. This journal is a member of the Committee on Publication Ethics (COPE).
Average time from submission to first decision: 21 days
Among the topics in recent issues are:
- Adverse Events
- Angiogenesis Inhibitors
- Basic and Translational Research
- Drug Development for Pediatric Populations
- Drug-Induced Hematologic Toxicity
- Epigenetics
- Genomic Analyses
- Global Regulatory Perspectives
- Hazard Identification
- High Throughput Pathology
- Immunomodulation
- International Accreditation For Toxicologic Pathologists
- Lesions
- Neoplasia and Hyperplasia
- Risk Assessment
- Risk Communication
- Safety Assessments
- Tumor Pathology
- Use of Animal Models
Toxicologic Pathology also publishes timely in-depth current topic review papers, symposia papers, brief communications, best practice articles for scientific and regulatory processes, and position papers on current regulatory issues.
Toxicologic Pathology is dedicated to the promotion of human, animal, and environmental health through the dissemination of knowledge, techniques, and guidelines to enhance the understanding and practice of toxicologic pathology.
Toxicologic Pathology, the official journal of the Society of Toxicologic Pathology, the British Society of Toxicological Pathology and the European Society of Toxicologic Pathology, will publish Original Research Articles, Symposium Articles, Review Articles, Meeting Reports, New Techniques, and Position Papers that are relevant to toxicologic pathology. Relevant topics include reports on safety assessment of pharmaceuticals, chemicals, food additives, pesticides, environmentally relevant chemicals, and medical devices; risk characterization of xenobiotics; investigative studies that contribute to refinement of the safety assessment process; mechanistic studies that provide a basis for interpreting and predicting toxicologic outcome; emerging approaches and methods in toxicologic pathology; spontaneous diseases that may influence toxicology studies, and animal and alternative models relevant to toxicologic pathology. Studies of botanicals and their extracts must include appropriate characterization of the components and concentration of active ingredients; crude extracts will not be accepted. Reviews may be contributed or invited. This journal is a member of the Committee on Publication Ethics (COPE).
Average time from submission to first decision: 21 days
| Kevin Keane, DVM, PhD, FIATP | Blueprint Medicines, Cambridge, MA, USA |
| Kellyanna Bussell | Cary, NC, USA |
| Beth Mahler | Experimental Pathology Labs, NC, USA |
| Ronnie Chamanza, BVSc, MSc, FRC Path, MRCVS, FIATP | Johnson & Johnson, Beerse, Belgium |
| Sundeep Chandra, BVSc, PhD, DACVPBVSc, DACVP | Biomarin, San Rafael, CA, USA |
| Jeff Everitt, DVM | Duke University School of Medicine, USA |
| Beatrice Gauthier, DVM | Sanofi-Aventis Recherche et Developpement, Montpellier, France |
| Peter Hall, BVetMed, MRCVS, PhD, FRCPath | UCB Pharma Ltd., Berkshire, UK |
| Renee Hukkanen, DVM, MS, DACVP | Amgen, Cambridge, MA, USA |
| Ramesh Kovi, BVSc & AH, MVSc, PhD, DACVP, DABT, FIATP | Pfizer, Cambridge, MA, USA |
| Daniel Patrick | Eli Lilly and Company, Kalamazoo, MI, USA |
| Brad Bolon, DVM, MS, PhD, DACVP, DABT, FATS, FIATP, FRCPath | GEMpath, Inc., Longmont, CO, USA |
| Susan A. Elmore, MS, DVM, DACVP, DABT, FIATP | Elmore Pathology, Chapel Hill, NC,USA |
| Abraham Nyska, DVM, PhD, FIATP | Sackler School of Medicine, Tel Aviv University, Timrat, Israel |
| Jerrold M. Ward, DVM, PhD, FIATP | Global Vet Pathology, USA |
| Tracy Carlson, BS, DVM, PhD, DACVP | Charles River, Mattawan, MI |
| Elizabeth McInnes, BVSc, PhD, FRCPath, MRCVS, FIATP | Syngenta, Berks, UK |
| Erin Quist, DVM, MS, PhD, DACVP | EPL Inc, Research Triangle Park, NC, USA |
| Mark Hoenerhoff, DVM, PhD, DACVP, FIATP | University of Michigan Medical School, Ann Arbor, MI, USA |
| Dinesh Bangari, BVSc, MVSc, MS, PhD, DACVP | Sanofi, Framingham, MA USA |
| Duane Belote, DVM, DACVP | Covance Laboratories Inc., Chantilly, VA, USA |
| Brad Blakenship, DVM, DACVP | Charles River Laboratories, Reno, NV, USA |
| Rogely Boyce, DVM, PhD, DACVP | Beechy Ridge ToxPath LLC, Clay, WV, USA |
| Cory Brayton, DVM, ACLAM, DACVP | Johns Hopkins University School of Medicine, Baltimore, MD, USA |
| Danielle Brown, DVM, MS, DACVP, FIATP | Charles River Laboratories, Durham, NC, USA |
| Erica Eggers Carroll, DVM, PhD, DACVP, DABT | Labcorp, Greenfield, IN, USA |
| Russ Cattley, VMD, PhD, FIATP | Auburn University, Auburn, AL, USA |
| Ronnie Chamanza, BVSc, MSc, FRC Path, MRCVS, FIATP | Johnson & Johnson, Beerse, Belgium |
| Franck Chanut, DVM, MSc, DECVP, DESV-AP | Sanofi, Paris, France |
| Shambhunath Choudhary, BVSc, PhD, DACVP | Pfizer Inc. Pearl River, NY USA |
| Mark Cline, DVM, PhD, DACVP, FIATP | Wake Forest School of Medicine, Winston-Salem, NC, USA |
| Samuel M. Cohen, MD, PhD, FIATP | University of Nebraska Medical Center, Omaha, NE, USA |
| Kevin Donnelly, DVM, PhD | Theravance Inc., San Francisco, CA, USA |
| Michael R. Elwell, DVM, PhD, FIATP | Apex ToxPath, Apex, NC, USA |
| Jurgen Funk, Dr. Med. Vet. | Hoffman-LaRoche, Basel, Switzerland |
| Kathleen A. Funk, DVM, PhD, DACVP | Experimental Pathology Laboratories Inc., Sterling, VA, USA |
| Santokh Gill, PhD | Health Canada, Ottawa, Canada |
| Adam Hargreaves, FRCPath, DACVP | PathCelerate Ltd., Cheshire, UK |
| Johannes Harleman, DVM, PhD, ERT, FIATP | Global Preclinical Development & Management GMCRA, Darmstadt, Germany |
| Wanda M. Haschek-Hock, BVSc, PhD, DACVP, DABT, FIATP | University of Illinois, Urbana, IL, USA |
| Paul Howroyd, FRCPath | Charles River Laboratories, Tranent, UK |
| Armando Irizarry, DVM, PhD, DACVP | Eli Lilly & Company, Indianapolis, IN, USA |
| Kyathanahalli Janardhan, BVSc, MVSc, PhD, DACVP | Abbvie, North Chicago, IL, USA |
| Takahito Kambara, BVSc, MVSc, PhD, FRCPath | AbbVie Inc., North Chicago, IL, USA |
| Timothy LaBranche, DVM PhD DACVP | Blueprint Medicines, Cambridge, MA, USA |
| Heike Antje Marxfeld, PhD, DiplECVP, EBVS | BASF, Ludwigshafen, Germany |
| Sandra McBride, PhD | Social & Scientific Systems, Durham, NC, USA |
| Elizabeth McInnes, BVSc, PhD, FRCPath, MRCVS, FIATP | Syngenta, Berks, UK |
| Mark Mense, DVM, PhD, MBA, DACVP, DABT, PMP, FIATP | Labcorp Drug Development, Chantilly, VA, USA |
| James Morrison, DVM, DACVP | Charles River Laboratories Pathology, Durham, NC, USA |
| Leslie Ann Obert, DVM, PhD, DACVP | GlaxoSmithKline, Collegeville, PA, USA |
| Ricardo Ochoa, DVM, PhD, DACVP, FIATP | Pre-Clinical Safety Inc., Niantic, CT, USA |
| Arun Pandiri, BVSc&AH, MS, PhD, DACVP | Experimental Pathology Laboratories, Research Triangle Park, NC, USA |
| Daniel Patrick, DVM, DACVP, DABT | Charles River Laboratories, Mattawan, MI, USA |
| Giovanni Pellegrini, DVM, PhD, DECVP | AstraZeneca, Gothenburg, Sweden |
| Erin M. Quist, DVM, MS, PhD, DACVP | Experimental Pathology Laboratories, Research Triangle Park, NC, USA |
| Zaher A. Radi, DVM, MBA, PhD, DABT, DACVP | Pfizer, Cambridge, MA, USA |
| Deepa Rao, BVSc, MS, PhD, DABT, DACVP, FIATP | Greenfield Pathology Services, Inc., Ellicott City, MD, USA |
| Jerry Rehg, DVM | St. Jude Children's Research Hospital, Memphis, TN, USA |
| Amera K. Remick, DVM, DACVP, DABT | Charles River Laboratories, Durham, NC, USA |
| Matthias Rinke, DVM, FIATP | Wuelfrath, Germany |
| Susanne Rittinghausen, DVM, Dr. Med. Vet. Habil. | Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany |
| Catherine L Ross DVM MSc(VetPath) MSc(ApplTox) MRCVS | Covance Laboratories Limited, North Yorkshire, United Kingdom |
| Melissa M. Schutten, DVM, PhD, DACVP | Ultragenyx Pharmaceuticals, Novato, CA USA |
| Cheryl Scudamore, BVSc, PhD, MRCVS, FHEA, FRCPath | ExePathology, Devon, UK |
| Keith R. Shockley, PhD | NIEHS/NIH, Research Triangle Park, NC, USA |
| Kanaka Tatikola, MS | Johnson & Johnson, Bridgewater, NJ, USA |
| Reginald A. Valdez, DVM, MS, PhD, DACVP | Amgen, Cambridge, MA, USA |
| Justin Vidal, DVM, PhD | Charles River Laboratories Inc, Mattawa, MI, USA |
| Jonathan Werner, DVM, PhD, DACVP | Amgen, Thousand Oaks, CA |
| Matthew Wheeler, PhD | CDC/NIOSH, Cincinnati, OH, USA |
| Cynthia J. Willson, MS, PhD, DVM, DACVP | Integrated Laboratory Systems, Research Triangle Park, NC, USA |
| Zbigniew W. Wojcinski, DVM, DVSc, DACVP, DABT, FIATP | Toxicology & Pathology Consulting, LLC, Hillsborough, NC USA |
| Jeff Wolf, DVM, DACVP | Experimental Pathology Laboratories Inc., Sterling, VA, USA |
| Charles Wood, DVM, PhD, DACVP | Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA |
All manuscripts to Toxicologic Pathology should be submitted via the SAGE Track online submission site at https://mc.manuscriptcentral.com/toxpath. The instructions for authors can be downloaded at that site as well.